http://medicalxpress.com/ en-us Medical Xpress provides the latest news from The Translational Genomics Research Institute The safety and preliminary efficacy of a new class of tumor fighting drugs were reported today by Scottsdale Healthcare's Virginia G. Piper Cancer Center Clinical Trials and the Translational Genomics Research Institute (TGen). http://medicalxpress.com/news/2013-04-clinical-trial-class-cancer-drugs.html Cancer Tue, 09 Apr 2013 15:00:01 EST news284730889 The nanoparticle drug BIND-014 is effective against multiple solid tumors, according to results generated by the Translational Genomics Research Institute (TGen) and Scottsdale Healthcare, and presented today at the American Association for Cancer Research (AACR) Annual Meeting 2013. http://medicalxpress.com/news/2013-04-clinical-trial-results-bind-aacr.html Cancer Tue, 09 Apr 2013 13:35:53 EST news284733345 The scientific benefits of whole genome sequencing at the Translational Genomics Research Institute (TGen) will be presented at the 14th International Myeloma Workshop, April 3-7 at the Kyoto International Conference Center. http://medicalxpress.com/news/2013-04-tgen-professor-discusses-benefits-genome.html Cancer Wed, 03 Apr 2013 09:51:25 EST news284201476 The FDA has approved a thyroid cancer drug successfully tested at Virginia G. Piper Cancer Center Clinical Trials, a partnership of Scottsdale Healthcare and the Translational Genomics Research Institute (TGen). http://medicalxpress.com/news/2013-03-cancer-drug-clinical-trial-fda.html Cancer Wed, 27 Mar 2013 09:56:56 EST news283597005 More northwest Ohio garden centers this spring are teaming up with an Arizona-based biomedical research organization to fight pancreatic cancer through the sale of purple flowers, which symbolize the nation's fourth leading cause of cancer death. http://medicalxpress.com/news/2013-03-purple-grow-campaign-season.html Cancer Tue, 19 Mar 2013 09:45:56 EST news282905150 A multi-center Phase III clinical trial demonstrates that Abraxane (nab-paclitaxel) plus gemcitabine is the first combination of cancer drugs to extend survival of late-stage pancreatic cancer patients compared to standard treatment. http://medicalxpress.com/news/2013-01-drug-combination-pancreatic-cancer-patient.html Cancer Tue, 22 Jan 2013 18:00:01 EST news278097991 A fast growing, flesh-eating fungus killed 5 people following a massive tornado that devastated Joplin, Mo., according to two new studies based on genomic sequencing by the Translational Genomics Research Institute (TGen) and the U.S. Centers for Disease Control and Prevention (CDC). http://medicalxpress.com/news/2012-12-fungus-responsible-deaths-massive-tornado.html Diseases, Conditions, Syndromes Fri, 14 Dec 2012 18:31:55 EST news274732305 Genomic sequencing has revealed therapeutic drug targets for difficult-to-treat, metastatic triple-negative breast cancer (TNBC), according to an unprecedented study by the Translational Genomic Research Institute (TGen) and US Oncology Research. http://medicalxpress.com/news/2012-12-tgen-us-oncology-treatment-metastatic-triple-negative.html Cancer Thu, 06 Dec 2012 15:19:37 EST news274029561 A new cancer drug combination demonstrated significant improvement in overall survival of late-stage pancreatic cancer patients compared to those receiving standard treatment, according to results of a Phase III clinical trial led by physicians from Scottsdale Healthcare's Virginia G. Cancer Center Clinical Trials, a partnership with the Translational Genomics Research Institute (TGen). http://medicalxpress.com/news/2012-11-phase-iii-worldwide-drug-patients.html Cancer Mon, 19 Nov 2012 13:14:23 EST news272553254 Whole genome sequencing—spelling out all 3 billion letters in the human genome—"is an obvious and powerful method for advancing our understanding of pancreatic cancer," according to a new study from TGen, Mayo Clinic and Scottsdale Healthcare published today. http://medicalxpress.com/news/2012-10-wgs-multiple-pancreatic-cancer-patients.html Cancer Wed, 10 Oct 2012 17:00:08 EST news269106114 Knowing how tumors evolve can lead to new treatments that could help prevent cancer from recurring, according to a study published today by the Translational Genomics Research Institute (TGen) and Scottsdale Healthcare. http://medicalxpress.com/news/2012-09-clonal-evolution-maxillary-sinus-carcinoma.html Cancer Fri, 28 Sep 2012 17:00:10 EST news268063040 A Phase I/II, multi-center trial designed to test the safety and preliminary efficacy of a first in class cancer treatment opened worldwide today at the Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, a partnership between Scottsdale Healthcare and the Translational Genomics Research Institute (TGen). PR610 is designed to become activated in tissues with low levels of oxygen, which is characteristic of many cancers. This "targeted" approach should deliver more active drug to cancer tissue and less active drug to normal tissue. http://medicalxpress.com/news/2012-08-non-small-cell-lung-cancer.html Cancer Wed, 29 Aug 2012 16:11:37 EST news265475483 Researchers at the Translational Genomics Research Institute (TGen) have developed a method of isolating biospecimens that could lead to a less costly, less invasive and more accurate way of diagnosing chronic kidney disease, or CKD. http://medicalxpress.com/news/2012-07-tgen-method-isolates-biospecimens-treatment.html Diseases, Conditions, Syndromes Wed, 11 Jul 2012 09:46:06 EST news261218753 An investigational drug that acts like a Trojan Horse to deliver cancer killing agents for pancreatic cancer is being studied at the Virginia G. Piper Cancer Center Clinical Trials, a partnership between Scottsdale Healthcare and the Translational Genomics Research Institute (TGen) that treats cancer patients with promising new drugs. http://medicalxpress.com/news/2012-06-trial-drug-trojan-horse-pancreatic.html Cancer Thu, 14 Jun 2012 09:00:19 EST news258883210 The Translational Genomics Research Institute (TGen) and the Virginia G. Piper Cancer Center at Scottsdale Healthcare have conducted whole genome sequencing (WGS) of a rare nasal tract cancer called olfactory neuroblastoma (ONB). http://medicalxpress.com/news/2012-05-genome-sequencing-rare-olfactory-neuroblastoma.html Genetics Wed, 23 May 2012 17:00:22 EST news257010468